Olivia Corradin - Publications

Affiliations: 
2017 Biology Whitehead Institute (MIT), Cambridge, MA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hoang AT, Corradin O. Epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 37587380 DOI: 10.1038/s41386-023-01701-5  0.617
2022 Corradin O, Sallari R, Hoang AT, Kassim BS, Ben Hutta G, Cuoto L, Quach BC, Lovrenert K, Hays C, Gryder BE, Iskhakova M, Cates H, Song Y, Bartels CF, Hancock DB, et al. Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. Molecular Psychiatry. PMID 35301427 DOI: 10.1038/s41380-022-01477-y  0.652
2020 Factor DC, Barbeau AM, Allan KC, Hu LR, Madhavan M, Hoang AT, Hazel KEA, Hall PA, Nisraiyya S, Najm FJ, Miller TE, Nevin ZS, Karl RT, Lima BR, Song Y, ... ... Corradin O, et al. Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. Cell. PMID 32246942 DOI: 10.1016/J.Cell.2020.03.002  0.643
2018 Bailey SD, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri PC, Haibe-Kains B, Lupien M. Publisher Correction: ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nature Communications. 9: 16194. PMID 29633758 DOI: 10.1038/Ncomms16194  0.566
2017 Cohen AJ, Saiakhova A, Corradin O, Luppino JM, Lovrenert K, Bartels CF, Morrow JJ, Mack SC, Dhillon G, Beard L, Myeroff L, Kalady MF, Willis J, Bradner JE, Keri RA, et al. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome. Nature Communications. 8: 14400. PMID 28169291 DOI: 10.1038/Ncomms14400  0.585
2016 Corradin O, Cohen AJ, Luppino JM, Bayles IM, Schumacher FR, Scacheri PC. Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry. Nature Genetics. PMID 27643537 DOI: 10.1038/ng.3674  0.607
2015 Bailey SD, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri PC, Haibe-Kains B, Lupien M. ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nature Communications. 2: 6186. PMID 25645053 DOI: 10.1038/Ncomms7186  0.625
2015 Vučićević D, Corradin O, Ntini E, Scacheri PC, Ørom UA. Long ncRNA expression associates with tissue-specific enhancers. Cell Cycle (Georgetown, Tex.). 14: 253-60. PMID 25607649 DOI: 10.4161/15384101.2014.977641  0.575
2014 Corradin O, Scacheri PC. Enhancer variants: evaluating functions in common disease. Genome Medicine. 6: 85. PMID 25473424 DOI: 10.1186/s13073-014-0085-3  0.64
2014 Factor DC, Corradin O, Zentner GE, Saiakhova A, Song L, Chenoweth JG, McKay RD, Crawford GE, Scacheri PC, Tesar PJ. Epigenomic comparison reveals activation of "seed" enhancers during transition from naive to primed pluripotency. Cell Stem Cell. 14: 854-63. PMID 24905169 DOI: 10.1016/J.Stem.2014.05.005  0.612
2014 Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Cowper-Sal lari R, Lupien M, Markowitz S, Scacheri PC. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Research. 24: 1-13. PMID 24196873 DOI: 10.1101/Gr.164079.113  0.651
2012 Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF, Willis J, Moore JH, Tesar PJ, Laframboise T, Markowitz S, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science (New York, N.Y.). 336: 736-9. PMID 22499810 DOI: 10.1126/Science.1217277  0.61
Show low-probability matches.